Schisandra chinensis Oil Attenuates Aristolochic Acid I-Induced Nephrotoxicity in vivo and in vitro

Chin J Integr Med. 2022 Jul;28(7):603-611. doi: 10.1007/s11655-022-3574-z. Epub 2022 Apr 7.

Abstract

Objective: To investigate the protective effects of Schisandra chinensis oil (SCEO) against aristolochic acid I (AA I)-induced nephrotoxicity in vivo and in vitro and elucidate the underlying mechanism.

Methods: C57BL/6 mice were randomly divided into 5 groups according to a random number table, including control group, AA I group, and AA I +SCEO (0.25, 0.5 and 1 g/kg) groups (n=5 per group). Pretreatment with SCEO was done for 2 days by oral administration, while the control and AA I groups were treated with sodium carboxymethyl cellulose. Mice of all groups except for the control group were injected intraperitoneally with AA I (5 mg/kg) from day 3 until day 7. Histopathological examination and apoptosis of kidney tissue were observed by hematoxylin and eosin and TdT-mediated dUTP nick-end labeling (TUNEL) staining, respectively. The levels of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and serum creatinine (SCr), as well as renal malondialdehyde (MDA), glutathione, r-glutamyl cysteingl+glycine (GSH), and superoxide dismutase (SOD) were analyzed using enzyme-linked immunosorbent assay (ELISA). Expressions of hepatic cytochrome P450 1A1 (CYP1A1), CYP1A2, and nad(p)hquinonedehydrogenase1 (NQO1) were analyzed using ELISA, quantitative real-time polymerase chain reaction (qPCR) and Western blot, respectively. In vitro, SCEO (40 µ g/mL) was added 12 h before treatment with AA I (40 µ mol/mL for 48 h) in human renal proximal tubule cell line (HK-2), then apoptosis and reactive oxygen species (ROS) were analyzed by flow cytometry.

Results: SCEO 0.5 and 1 g/kg ameliorated histopathological changes and TUNEL+ staining in the kidney tissues of mice with AA I-induced nephrotoxicity, and reduced serum levels of ALT, AST, BUN and SCr (P<0.01 or P<0.05). SCEO 0.5 and 1 g/kg alleviated the ROS generation in kidney, containing MDA, GSH and SOD (P<0.01 or P<0.05). SCEO 1 g/kg increased the expressions of CYP1A1 and CYP1A2 and decreased NQO1 level in the liver tissues (P<0.01 or P<0.05). Besides, in vitro studies also demonstrated that SCEO 40 µ g/mL inhibited apoptosis and ROS generation (P<0.05 or P<0.01).

Conclusions: SCEO can alleviate AA I-induced kidney damage both in vivo and in vitro. The protective mechanism may be closely related to the regulation of metabolic enzymes, thereby inhibiting apoptosis and ROS production.

Keywords: Schisandra chinensis oil; apoptosis; aristolochic acid I; metabolic enzymes; nephrotoxicity; reactive oxygen species.

Publication types

  • Evaluation Study

MeSH terms

  • Animals
  • Apoptosis
  • Aristolochic Acids* / toxicity
  • Cytochrome P-450 CYP1A1 / metabolism
  • Cytochrome P-450 CYP1A2 / metabolism
  • Glutathione / metabolism
  • Kidney / drug effects
  • Kidney Diseases* / chemically induced
  • Kidney Diseases* / drug therapy
  • Mice
  • Mice, Inbred C57BL
  • Oxidative Stress
  • Plant Oils* / pharmacology
  • Plant Oils* / therapeutic use
  • Protective Agents* / therapeutic use
  • Reactive Oxygen Species / metabolism
  • Schisandra*
  • Superoxide Dismutase / metabolism

Substances

  • Aristolochic Acids
  • Plant Oils
  • Protective Agents
  • Reactive Oxygen Species
  • aristolochic acid I
  • Cytochrome P-450 CYP1A1
  • Cytochrome P-450 CYP1A2
  • Superoxide Dismutase
  • Glutathione